On the other hand, BHQ880, the DKK1-neutralizing antibody, can increase osteoblast differentiation, blocking the negative effect of MM cells on osteoblastogenesis and reducing IL6 secretion in MM patients [75]. This evidence concerns the gene IL6 and Miyoshi myopathy.